CalciMedica (CALC) EBITDA

Annual EBITDA

-$34.19 M
-$26.55 M-347.50%

December 31, 2023


Summary


Performance

CALC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCALCprofitabilitymetrics:

Quarterly EBITDA

-$5.72 M
+$794.00 K+12.19%

September 30, 2024


Summary


Performance

CALC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCALCprofitabilitymetrics:

TTM EBITDA

-$18.46 M
-$900.00 K-5.13%

September 30, 2024


Summary


Performance

CALC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCALCprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CALC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-347.5%+0.5%-4.8%
3 y3 years-16.1%+74.4%+28.4%
5 y5 years-20.4%+74.4%+28.4%

CALC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-347.5%at low-267.8%+74.4%-141.6%+46.0%
5 y5-year-347.5%+8.1%-267.8%+74.4%-141.6%+46.6%
alltimeall time-347.5%+8.1%-267.8%+74.4%-141.6%+46.6%

CalciMedica EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.72 M(-12.2%)
-$18.46 M(+5.1%)
Jun 2024
-
-$6.51 M(+13.3%)
-$17.56 M(-0.3%)
Mar 2024
-
-$5.75 M(+1118.6%)
-$17.61 M(-48.5%)
Dec 2023
-$34.19 M(+347.5%)
-$472.00 K(-90.2%)
-$34.19 M(+12.8%)
Sep 2023
-
-$4.82 M(-26.6%)
-$30.31 M(+5.4%)
Jun 2023
-
-$6.57 M(-70.6%)
-$28.76 M(+11.6%)
Mar 2023
-
-$22.33 M(-754.9%)
-$25.77 M(+237.3%)
Dec 2022
-$7.64 M(-77.6%)
$3.41 M(-204.1%)
-$7.64 M(-61.0%)
Sep 2022
-
-$3.27 M(-8.4%)
-$19.61 M(-19.0%)
Jun 2022
-
-$3.58 M(-14.8%)
-$24.22 M(-14.3%)
Mar 2022
-
-$4.20 M
-$28.26 M
DateAnnualQuarterlyTTM
Dec 2021
-$34.08 M(+15.8%)
-
-
Dec 2021
-
-$8.56 M(+8.7%)
-$34.08 M(-1.4%)
Sep 2021
-
-$7.88 M(+3.5%)
-$34.58 M(+3.5%)
Jun 2021
-
-$7.61 M(-24.0%)
-$33.42 M(+5.3%)
Mar 2021
-
-$10.02 M(+10.5%)
-$31.75 M(+7.9%)
Dec 2020
-$29.44 M(-20.9%)
-$9.06 M(+34.8%)
-$29.44 M(-4.5%)
Sep 2020
-
-$6.72 M(+13.1%)
-$30.82 M(-10.3%)
Jun 2020
-
-$5.95 M(-22.8%)
-$34.37 M(+20.9%)
Mar 2020
-
-$7.70 M(-26.2%)
-$28.43 M(+37.2%)
Dec 2019
-$37.20 M(+31.0%)
-$10.44 M(+1.6%)
-$20.73 M(+101.6%)
Sep 2019
-
-$10.28 M
-$10.28 M
Dec 2018
-$28.39 M
-
-

FAQ

  • What is CalciMedica annual EBITDA?
  • What is the all time high annual EBITDA for CalciMedica?
  • What is CalciMedica annual EBITDA year-on-year change?
  • What is CalciMedica quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CalciMedica?
  • What is CalciMedica quarterly EBITDA year-on-year change?
  • What is CalciMedica TTM EBITDA?
  • What is the all time high TTM EBITDA for CalciMedica?
  • What is CalciMedica TTM EBITDA year-on-year change?

What is CalciMedica annual EBITDA?

The current annual EBITDA of CALC is -$34.19 M

What is the all time high annual EBITDA for CalciMedica?

CalciMedica all-time high annual EBITDA is -$7.64 M

What is CalciMedica annual EBITDA year-on-year change?

Over the past year, CALC annual EBITDA has changed by -$26.55 M (-347.50%)

What is CalciMedica quarterly EBITDA?

The current quarterly EBITDA of CALC is -$5.72 M

What is the all time high quarterly EBITDA for CalciMedica?

CalciMedica all-time high quarterly EBITDA is $3.41 M

What is CalciMedica quarterly EBITDA year-on-year change?

Over the past year, CALC quarterly EBITDA has changed by +$31.00 K (+0.54%)

What is CalciMedica TTM EBITDA?

The current TTM EBITDA of CALC is -$18.46 M

What is the all time high TTM EBITDA for CalciMedica?

CalciMedica all-time high TTM EBITDA is -$7.64 M

What is CalciMedica TTM EBITDA year-on-year change?

Over the past year, CALC TTM EBITDA has changed by -$846.00 K (-4.80%)